Pavan Cheruvu
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Pavan K.
Cheruvu is currently Chief Executive Officer & Director at Amanat Acquisition Corp.
Former positions include Chief Executive Officer at Sio Gene Therapies, Inc. from 2018 to 2018, Chief Executive Officer at Axovant Sciences, Inc. from 2018 to 2020, and President, Chief Executive Officer & Director at Bitterroot Bio, Inc. Education includes undergraduate studies at Duke University, graduate studies at the University of Oxford, and a doctorate from Harvard Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
6,9% | 20-05-2026 | 150.000 ( 6,9% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Algemeen Directeur | 01-02-2026 |
| SIO GENE THERAPIES INC. | Algemeen Directeur | 31-01-2022 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Algemeen Directeur | 01-12-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau